BDBM50310473 CHEMBL1080245::N-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-cyclobutyl-1H-benzo[d]imidazol-5-yl)acetamide

SMILES: CC(=O)Nc1ccc2n(C3CCC3)c(nc2c1)-c1nonc1N

InChI Key: InChIKey=DVZMVUPDOIJUSH-UHFFFAOYSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50310473   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Ribosomal protein S6 kinase (P70S6K) (Homo sapiens (Human))	BDBM50310473 (CHEMBL1080245 | N-(2-(4-amino-1,2,5-oxadiazol-3-yl...) Show SMILES CC(=O)Nc1ccc2n(C3CCC3)c(nc2c1)-c1nonc1N Show InChI InChI=1S/C15H16N6O2/c1-8(22)17-9-5-6-12-11(7-9)18-15(13-14(16)20-23-19-13)21(12)10-3-2-4-10/h5-7,10H,2-4H2,1H3,(H2,16,20)(H,17,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.20E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals, Inc. Curated by ChEMBL					Assay Description Inhibition of p70S6K assessed as decrease in NADH absorbance at 340 nm in the presence of				Bioorg Med Chem Lett 19: 5191-4 (2009) Article DOI: 10.1016/j.bmcl.2009.07.022 BindingDB Entry DOI: 10.7270/Q2KP8287
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 beta (Homo sapiens (Human))	BDBM50310473 (CHEMBL1080245 | N-(2-(4-amino-1,2,5-oxadiazol-3-yl...) Show SMILES CC(=O)Nc1ccc2n(C3CCC3)c(nc2c1)-c1nonc1N Show InChI InChI=1S/C15H16N6O2/c1-8(22)17-9-5-6-12-11(7-9)18-15(13-14(16)20-23-19-13)21(12)10-3-2-4-10/h5-7,10H,2-4H2,1H3,(H2,16,20)(H,17,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>3.30E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals, Inc. Curated by ChEMBL					Assay Description Inhibition of GSK3beta assessed as decrease in NADH absorbance at 340 nm in the presence of				Bioorg Med Chem Lett 19: 5191-4 (2009) Article DOI: 10.1016/j.bmcl.2009.07.022 BindingDB Entry DOI: 10.7270/Q2KP8287
					More data for this Ligand-Target Pair
Rho-associated protein kinase 1 (Homo sapiens (Human))	BDBM50310473 (CHEMBL1080245 | N-(2-(4-amino-1,2,5-oxadiazol-3-yl...) Show SMILES CC(=O)Nc1ccc2n(C3CCC3)c(nc2c1)-c1nonc1N Show InChI InChI=1S/C15H16N6O2/c1-8(22)17-9-5-6-12-11(7-9)18-15(13-14(16)20-23-19-13)21(12)10-3-2-4-10/h5-7,10H,2-4H2,1H3,(H2,16,20)(H,17,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>3.30E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals, Inc. Curated by ChEMBL					Assay Description Inhibition of ROCK1 assessed as decrease in NADH absorbance at 340 nm in the presence of				Bioorg Med Chem Lett 19: 5191-4 (2009) Article DOI: 10.1016/j.bmcl.2009.07.022 BindingDB Entry DOI: 10.7270/Q2KP8287
					More data for this Ligand-Target Pair
cAMP-dependent protein kinase (PKA) (Homo sapiens (Human))	BDBM50310473 (CHEMBL1080245 | N-(2-(4-amino-1,2,5-oxadiazol-3-yl...) Show SMILES CC(=O)Nc1ccc2n(C3CCC3)c(nc2c1)-c1nonc1N Show InChI InChI=1S/C15H16N6O2/c1-8(22)17-9-5-6-12-11(7-9)18-15(13-14(16)20-23-19-13)21(12)10-3-2-4-10/h5-7,10H,2-4H2,1H3,(H2,16,20)(H,17,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>3.30E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals, Inc. Curated by ChEMBL					Assay Description Inhibition of PKAalpha assessed as decrease in NADH absorbance at 340 nm in the presence of				Bioorg Med Chem Lett 19: 5191-4 (2009) Article DOI: 10.1016/j.bmcl.2009.07.022 BindingDB Entry DOI: 10.7270/Q2KP8287
					More data for this Ligand-Target Pair